In a study using a colon cancer-bearing nude mice xenograft model, combined treatment with COX-2 and 5-LOX inhibitors, resulted in better tumor growth inhibition than using a single agent alone [20,50]. This evidence concerns the gene ALOX5 and malignant colon neoplasm.